Correlation Between BioNTech and Asure Software

Can any of the company-specific risk be diversified away by investing in both BioNTech and Asure Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Asure Software into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioNTech SE and Asure Software, you can compare the effects of market volatilities on BioNTech and Asure Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Asure Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Asure Software.

Diversification Opportunities for BioNTech and Asure Software

0.56

Correlation Coefficient

BioNTech  Asure Software

Very weak diversification

The 3 months correlation between BioNTech and Asure is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Asure Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Asure Software and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Asure Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Asure Software has no effect on the direction of BioNTech i.e., BioNTech and Asure Software go up and down completely randomly.

Pair Corralation between BioNTech and Asure Software

Given the investment horizon of 90 days BioNTech SE is expected to under-perform the Asure Software. But the stock apears to be less risky and, when comparing its historical volatility, BioNTech SE is 1.07 times less risky than Asure Software. The stock trades about -0.07 of its potential returns per unit of risk. The Asure Software is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  941.00  in Asure Software on December 28, 2024 and sell it today you would earn a total of  54.00  from holding Asure Software or generate 5.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

BioNTech SE  vs.  Asure Software

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Asure Software

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Asure Software are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Asure Software may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with BioNTech and Asure Software

The main advantage of trading using opposite BioNTech and Asure Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Asure Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Asure Software will offset losses from the drop in Asure Software's long position.

The idea behind BioNTech SE and Asure Software pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.